Paolo Mignatti
About
Paolo Mignatti is a scholar working on Molecular Biology, Cancer Research and Hematology.
According to data from OpenAlex, Paolo Mignatti has authored 98 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 52 papers in Cancer Research and 25 papers in Hematology. Recurrent topics in Paolo Mignatti's work include Protease and Inhibitor Mechanisms (48 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Angiogenesis and VEGF in Cancer (21 papers). Paolo Mignatti is often cited by papers focused on Protease and Inhibitor Mechanisms (48 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Angiogenesis and VEGF in Cancer (21 papers). Paolo Mignatti collaborates with scholars based in United States, Italy and Canada. Paolo Mignatti's co-authors include Daniel B. Rifkin, E. Robbins, Giuseppe Pintucci, Aubrey C. Galloway, Takashi Morimoto, Graziano Seghezzi, Arthur Winer, Sylvia Adams, Sara Monea and D B Rifkin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Paolo Mignatti
96 papers receiving 8.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Paolo Mignatti United States | 40 | 4.5k | 3.7k | 2.1k | 1.4k | 1.4k | 98 | 8.9k | ||
| Olli Saksela Finland | 37 | 5.5k 1.2× | 3.2k 0.9× | 2.8k 1.4× | 1.5k 1.1× | 1.4k 1.0× | 82 | 9.6k | ||
| Kaoru Miyazaki Japan | 52 | 3.5k 0.8× | 3.2k 0.9× | 2.4k 1.2× | 1.3k 0.9× | 2.3k 1.6× | 181 | 8.3k | ||
| Suneel Apte United States | 64 | 4.7k 1.0× | 4.8k 1.3× | 2.5k 1.2× | 1.8k 1.2× | 2.2k 1.6× | 191 | 11.7k | ||
| Reuven Reich Israel | 59 | 5.4k 1.2× | 3.4k 0.9× | 3.0k 1.4× | 993 0.7× | 1.4k 1.0× | 202 | 11.2k | ||
| John J. Reynolds United Kingdom | 63 | 4.3k 1.0× | 5.5k 1.5× | 3.5k 1.7× | 1.9k 1.3× | 1.8k 1.3× | 186 | 12.6k | ||
| Leif R. Lund Denmark | 56 | 3.8k 0.9× | 5.8k 1.6× | 2.9k 1.4× | 2.7k 1.9× | 2.1k 1.5× | 125 | 10.5k | ||
| Yuen Shing United States | 29 | 7.1k 1.6× | 3.3k 0.9× | 1.9k 0.9× | 651 0.5× | 1.5k 1.1× | 57 | 10.4k | ||
| Thiennu H. Vu United States | 21 | 4.2k 0.9× | 3.3k 0.9× | 2.4k 1.1× | 887 0.6× | 869 0.6× | 30 | 9.0k | ||
| Elena I. Deryugina United States | 46 | 3.8k 0.8× | 3.8k 1.0× | 3.6k 1.7× | 984 0.7× | 1.8k 1.3× | 71 | 9.4k | ||
| Rafael Fridman United States | 55 | 3.4k 0.8× | 4.4k 1.2× | 3.6k 1.7× | 1.3k 0.9× | 1.6k 1.2× | 109 | 8.3k |
Countries citing papers authored by Paolo Mignatti
Since
Specialization
Citations
This map shows the geographic impact of Paolo Mignatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Mignatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Mignatti more than expected).
Fields of papers citing papers by Paolo Mignatti
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Paolo Mignatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Mignatti. The network helps show where Paolo Mignatti may publish in the future.
Co-authorship network of co-authors of Paolo Mignatti
This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Mignatti. A scholar is included among the top collaborators of Paolo Mignatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Mignatti. Paolo Mignatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Silvestro, Michele, Muhammad Yogi Pratama, Devon R. Byrd, et al.. (2022). The Nonproteolytic Intracellular Domain of Membrane-Type 1 Matrix Metalloproteinase Coordinately Modulates Abdominal Aortic Aneurysm and Atherosclerosis in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 42(10). 1244–1253.
2.
Gregory, Michael, et al.. (2017). Arrested Development: Infantile Hemangioma and the Stem Cell Teratogenic Hypothesis. Lymphatic Research and Biology. 15(2). 153–165.
3.
Winer, Arthur, Beth Harrison, Judy Zhong, et al.. (2016). Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Molecular Cancer Therapeutics. 15(10). 2370–2377.
4.
Mazzieri, Roberta, Giovanni Pietrogrande, Alessandro Gandelli, et al.. (2015). Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1. Cancer Research. 75(22). 4895–4909.
5.
Yang, Qing, Mukundan Attur, Thorsten Kirsch, et al.. (2015). Membrane-type 1 matrix metalloproteinase controls osteo- and chondrogenesis by a proteolysis-independent mechanism mediated by its cytoplasmic tail. Osteoarthritis and Cartilage. 23. A64–A64.
6.
Ferrari, Giovanni, Vitaly Terushkin, Martin Wolff, et al.. (2012). TGF-β1 Induces Endothelial Cell Apoptosis by Shifting VEGF Activation of p38MAPK from the Prosurvival p38β to Proapoptotic p38α. Molecular Cancer Research. 10(5). 605–614.
7.
Kallenbach, Klaus, Rolf Salcher, Albert Heim, et al.. (2009). Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3. Journal of Vascular Surgery. 49(3). 750–758.
8.
Cook, Brandoch D., Giovanni Ferrari, Giuseppe Pintucci, & Paolo Mignatti. (2008). TGF‐β1 induces rearrangement of FLK‐1–VE‐cadherin–β‐catenin complex at the adherens junction through VEGF‐mediated signaling. Journal of Cellular Biochemistry. 105(6). 1367–1373.
9.
Pintucci, Giuseppe, Paul Saunders, Iosif Gulkarov, et al.. (2005). Anti‐proliferative and anti‐inflammatory effects of topical MAPK inhibition in arterialized vein grafts. The FASEB Journal. 20(2). 398–400.
10.
Saunders, Paul, Giuseppe Pintucci, Costas Bizekis, et al.. (2004). Vein graft arterialization causes differential activation of mitogen-activated protein kinases. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1276–1284.
11.
Pintucci, Giuseppe, Ram Sharony, F.Gregory Baumann, et al.. (2003). Induction of stromelysin‐1 (MMP‐3) by fibroblast growth factor‐2 (FGF‐2) in FGF‐2−/− microvascular endothelial cells requires prolonged activation of extracellular signal‐regulated kinases‐1 and ‐2 (ERK‐1/2). Journal of Cellular Biochemistry. 90(5). 1015–1025.
12.
Malhotra, Sandeep K., Elliot Newman, David P. Eisenberg, et al.. (2002). Increased Membrane Type 1 Matrix Metalloproteinase Expression from Adenoma to Colon Cancer. Diseases of the Colon & Rectum. 45(4). 537–543.
13.
Monea, Sara, Kaisa Lehti, Jorma Keski‐Oja, & Paolo Mignatti. (2002). Plasmin activates pro‐matrix metalloproteinase‐2 with a membrane‐type 1 matrix metalloproteinase‐dependent mechanism. Journal of Cellular Physiology. 192(2). 160–170.
14.
Shamamian, Peter, Jess D. Schwartz, Sara Monea, et al.. (2001). Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis. Journal of Cellular Physiology. 189(2). 197–206.
15.
Liao, Francesca‐Fang, Yiwen Li, William O’Connor, et al.. (2000). Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.. PubMed. 60(24). 6805–10.
16.
Zanetta, Lucia, Stuart G. Marcus, Michael Dobryansky, et al.. (2000). Expression of von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: A potential method for objective assessment of tumor angiogenesis. International Journal of Cancer. 85(2). 281–288.
17.
Mignatti, Paolo & D B Rifkin. (1996). Plasminogen Activators and MatrixMetalloproteinases in Angiogenesis. PubMed. 49(1-3). 117–137.
18.
Peverali, Fiorenzo A., Stefano J. Mandriota, Paolo Ciana, et al.. (1994). Tumor cells secrete an Angiogenic factor that stimulates basic fibroblast growth factor and Urokinase expression in Vascular Endothelial cells. Journal of Cellular Physiology. 161(1). 1–14.
19.
Presta, Marco, Paolo Mignatti, Deborra Mullins, & David Moscatelli. (1985). Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production. Bioscience Reports. 5(9). 783–790.
20.
Krycève‐Martinerie, Cécile, et al.. (1981). Transformation-enhancing factor(s) released from chicken rous sarcoma cells: Effect on some transformation parameters. Virology. 112(2). 436–449.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Olli Saksela Breakdown of academic impact, for papers by Kaoru Miyazaki Breakdown of academic impact, for papers by Suneel Apte Breakdown of academic impact, for papers by Reuven Reich Breakdown of academic impact, for papers by John J. Reynolds Breakdown of academic impact, for papers by Leif R. Lund Breakdown of academic impact, for papers by Yuen Shing Breakdown of academic impact, for papers by Thiennu H. Vu Breakdown of academic impact, for papers by Elena I. Deryugina Breakdown of academic impact, for papers by Rafael Fridman